[HTML][HTML] Efficacy of a device to narrow the coronary sinus in refractory angina
S Verheye, EM Jolicœur, MW Behan… - … England Journal of …, 2015 - Mass Medical Soc
Background Many patients with coronary artery disease who are not candidates for
revascularization have refractory angina despite standard medical therapy. The balloon-expandable, …
revascularization have refractory angina despite standard medical therapy. The balloon-expandable, …
Treatment of refractory angina in patients not suitable for revascularization
TD Henry, D Satran, EM Jolicoeur - Nature Reviews Cardiology, 2014 - nature.com
A growing number of patients, particularly those with advanced, chronic coronary artery disease,
experience symptoms of angina that are refractory to treatment with β-blockers, calcium-…
experience symptoms of angina that are refractory to treatment with β-blockers, calcium-…
Epidemiology, management strategies, and outcomes of patients with chronic total coronary occlusion
L Azzalini, EM Jolicoeur, M Pighi, X Millán… - The American journal of …, 2016 - Elsevier
Factors influencing the management of patients with chronic total occlusion (CTO) are poorly
described. We sought to analyze the clinical and angiographic variables influencing the …
described. We sought to analyze the clinical and angiographic variables influencing the …
Clinical trial principles and endpoint definitions for paravalvular leaks in surgical prosthesis
…, V Jelnin, H Jilaihawi, EM Jolicoeur… - European heart …, 2018 - academic.oup.com
The VARC (Valve Academic Research Consortium) for transcatheter aortic valve
replacement set the standard for selecting appropriate clinical endpoints reflecting safety and …
replacement set the standard for selecting appropriate clinical endpoints reflecting safety and …
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34+ Cell Administration in Patients With Refractory Angina
…, AM Zeiher, CJ White, DJ Stewart, EM Jolicoeur… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives : This study tested whether intramyocardial (IM) administration of mobilized, purified
autologous CD34 + cells would improve total exercise time (TET) and angina frequency …
autologous CD34 + cells would improve total exercise time (TET) and angina frequency …
Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines
…, SL Carroll, JC Victor, PL L'allier, EM Jolicoeur… - Canadian Journal of …, 2012 - Elsevier
Refractory angina (RFA) is a debilitating disease characterized by cardiac pain resistant to
conventional treatments for coronary artery disease including nitrates, calcium-channel and β-…
conventional treatments for coronary artery disease including nitrates, calcium-channel and β-…
Transcatheter reduction of paravalvular leaks: a systematic review and meta-analysis
X Millán, S Skaf, L Joseph, C Ruiz, E García… - Canadian Journal of …, 2015 - Elsevier
… E. Marc Jolicœur is supported by research grants from les Fonds la Recherche du Québec
en santé (FRQS), the Canadian Institutes for Health Research (CIHR), and by la Fondation de …
en santé (FRQS), the Canadian Institutes for Health Research (CIHR), and by la Fondation de …
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of …
…, JH Traverse, RA Schatz, EM Jolicoeur… - European heart …, 2018 - academic.oup.com
… E Marc Jolicoeur , E Marc Jolicoeur … interactive voice response system daily diary in ACT-34,
and an electronic tablet based capture system in RENEW, in which patients entered daily …
and an electronic tablet based capture system in RENEW, in which patients entered daily …
Clopidogrel use and bleeding after coronary artery bypass graft surgery
…, LK Shaw, AJ Lodge, PK Smith, EM Jolicoeur… - American heart …, 2008 - Elsevier
… A variety of electronic sources of information were used to obtain the analysis data for this
… Clare, and E. Marc Jolicoeur have no financial disclosures to report. Financial disclosures …
… Clare, and E. Marc Jolicoeur have no financial disclosures to report. Financial disclosures …
The benefits conferred by radial access for cardiac catheterization are offset by a paradoxical increase in the rate of vascular access site complications with femoral …
L Azzalini, K Tosin, M Chabot-Blanchet, R Avram… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives : The purpose of this study was to assess whether the benefits conferred by
radial access (RA) at an individual level are offset by a proportionally greater incidence of …
radial access (RA) at an individual level are offset by a proportionally greater incidence of …